Profilo
Greg Troiano formerly worked at Translate Bio, Inc., as Chief Manufacturing Officer in 2021.
Mr. Troiano received his undergraduate degree and graduate degree from The Johns Hopkins University.
Precedenti posizioni note di Greg Troiano
| Società | Posizione | Fine |
|---|---|---|
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 14/09/2021 |
Formazione di Greg Troiano
| The Johns Hopkins University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Greg Troiano
